Equities

Integer Holdings Corp

Integer Holdings Corp

Actions
  • Price (EUR)134.00
  • Today's Change2.00 / 1.52%
  • Shares traded15.00
  • 1 Year change+64.42%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. It operates through Medical segment, which includes the cardio and vascular; cardiac rhythm management and neuromodulation, and advanced surgical; orthopedics and portable medical product lines. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease.

  • Revenue in USD (TTM)1.68bn
  • Net income in USD114.44m
  • Incorporated1997
  • Employees10.50k
  • Location
    Integer Holdings Corp5830 Granite Parkway., Suite 1150PLANO 75024United StatesUSA
  • Phone+1 (214) 618-5243
  • Fax+1 (302) 655-5049
  • Websitehttps://integer.net
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ITGR:NYQ since
announced
Transaction
value
Pulse Technologies IncDeal completed05 Jan 202405 Jan 2024Deal completed42.33%140.00m
Data delayed at least 15 minutes, as of Nov 26 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.